This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (25)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Eitan Shiloni, MD; Daniel Bitran, MD; Eliezer Rachmilewitz, MD; Arie L. Durst, MD

Arch Surg. 1983;118(8):929-932.

Abstract
• Thirteen patients underwent splenectomy for Gaucher's disease. All patients were Jewish; 12, of Ashkenazi descent, had the chronic (type 1) form, and one child, of Sephardic (Persian) origin, probably had the intermediate (type 3) form. Hypersplenism was the indication for surgery in 11 patients, mechanical problems in the remaining two. The weight of the resected spleens ranged from 1.06 to 13kg. Following surgery, hypersplenism (thrombocytopenia in particular) was improved, and the mechanical disturbances were relieved in all patients. There were no deaths and no morbidity related to the operative procedure. Long-term follow-up demonstrated progressive hepatomegaly without evidence of hepatic dysfunction in any of the patients. Bone marrow involvement manifested by osteoarticular complications appeared in five patients. Splenectomy is, we believe, a safe mode of treatment for type 1 Gaucher's disease.

(Arch Surg 1983;118:929-932)

Author Affiliations
From the Departments of Surgery B (Drs Shiloni, Bitran, and Durst) and Hematology (Dr Rachmilewitz), Hadassah University Hospital and Hebrew University—Hadassah Medical School, Jerusalem.

Footnotes
Accepted for publication Dec 27, 1982.

Reprint requests to Department of Surgery B, Hadassah University Hospital, PO Box 12000, Jerusalem 91120, Israel (Dr Shiloni).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?